{"date":"2025-10-08","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6499-2025-10-08-2212-uddl27","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-10-08","time":"22:12:57","subject":"Urocross Retrieval Sheath取出裝置獲美國FDA 510(k)核准，為Urocross Expander System首款獲准之搭配裝置","clause":"第10款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-10-08 22:12，「Urocross Retrieval Sheath取出裝置獲美國FDA 510(k)核准，為Urocross Expan」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-10-08-1837-ois9r3","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-10-08","time":"18:37:41","subject":"公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-10-08 18:37，「公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-10-08-1832-1j008tz","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-10-08","time":"18:32:51","subject":"代本公司重要子公司葡眾企業股份有限公司說明資安事件","clause":"第26款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-10-08 18:32，「代本公司重要子公司葡眾企業股份有限公司說明資安事件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-10-08-1703-vqkii","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-10-08","time":"17:03:21","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-10-08 17:03，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-10-08-1649-1ngnt5h","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-10-08","time":"16:49:45","subject":"公告本公司董事會決議辦理現金增資發行新股(補充發行價格資訊)","clause":"第9款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-10-08 16:49，「公告本公司董事會決議辦理現金增資發行新股(補充發行價格資訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-10-08-1625-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-10-08","time":"16:25:22","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-10-08 16:25，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2025-10-08-1603-1bcv4sg","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2025-10-08","time":"16:03:12","subject":"公告本公司取得會計師內部控制制度專案審查確信報告","clause":"第25款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2025-10-08 16:03，「公告本公司取得會計師內部控制制度專案審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-10-08-1527-1jre0tv","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-10-08","time":"15:27:46","subject":"衛福部核准本公司與佑民醫療社團法人佑民醫院合作之自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損計畫","clause":"第53款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-10-08 15:27，「衛福部核准本公司與佑民醫療社團法人佑民醫院合作之自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-10-08-1411-1insbm6","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-10-08","time":"14:11:25","subject":"本公司因近期股(債)價價格異常，應櫃買中心要求公布相關資訊，以利投資人區別暸解。","clause":"第53款","fact_date":"2025-10-08","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-10-08 14:11，「本公司因近期股(債)價價格異常，應櫃買中心要求公布相關資訊，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}